In the last two decades the treatment of ovarian and endometrial carcinomas has achieved tremendous progress thanks also to the implementation of multidisciplinary boards and to the progress of knowledge of molecular biology. These seminars will discuss the state of the art in the treatment of ovarian and endometrial carcinomas and the new horizons of therapy. Particular attention will be paid to the asperts connected with virtual multidisciplinarity and the management of patients, aspects of these current issues in the field of Covid-19 panepidemic. This multidisciplinary approach plays a pivotal role in the management of women affected by ovarin or endometrial cancer since referral to high-volume oncological center is to date mandatory to assure best practice. Furthermore the impact of new knowledge on the molecular biology of these neoplasms will be discussed in depth.